Abstract
Immune dependent growth and development of infectious agents and pathogenesis are increasingly being recognized as crucial for designing efficient immunotherapeutic approaches for Mycobacterium tuberculosis. Nitric oxide (NO) in the context of mycobacterial infection is an essential component of the protective armory of host innate immune system. However, the ability of NO to suppress host immune response questions the traditional view that production of NO is actually designed for anti-microbial mechanism. Human tuberculosis is considered as a prime example of a disease controlled dominantly by cell-mediated and not by humoral immunity. Interleukins like IL-12 and IL-8 play important roles in anti-tuberculosis immunity. While IL-8 has a central role in leukocyte recruitment to areas of granuloma formation, IL-12 helps in the generation of effective cell-mediated immune response in tuberculosis. NO shows an ability to inhibit mycobacterial infection by inducing innate-cytotoxic response and by increasing IL-8 induction. However, it may become a problem in later phase when it converts a protective Th1 response to a subversive Th2 response mainly by inhibiting IL-12 cytokine, thus acting as a potential regulator of Th1/Th2 response. This review intends to explore the possibilities that can be envisioned for exploring NO from immunotherapeutic perspectives in mycobacterial immunity.
Keywords: Mycobacterium tuberculosis, macrophage, nitric oxide, interleukin-12, Th1/Th2, immunoregulation
Current Signal Transduction Therapy
Title: Nitric Oxide: Friendly Rivalry in Tuberculosis
Volume: 2 Issue: 2
Author(s): Sangita Mukhopadhyay, Shiny Nair and Seyed E. Hasnain
Affiliation:
Keywords: Mycobacterium tuberculosis, macrophage, nitric oxide, interleukin-12, Th1/Th2, immunoregulation
Abstract: Immune dependent growth and development of infectious agents and pathogenesis are increasingly being recognized as crucial for designing efficient immunotherapeutic approaches for Mycobacterium tuberculosis. Nitric oxide (NO) in the context of mycobacterial infection is an essential component of the protective armory of host innate immune system. However, the ability of NO to suppress host immune response questions the traditional view that production of NO is actually designed for anti-microbial mechanism. Human tuberculosis is considered as a prime example of a disease controlled dominantly by cell-mediated and not by humoral immunity. Interleukins like IL-12 and IL-8 play important roles in anti-tuberculosis immunity. While IL-8 has a central role in leukocyte recruitment to areas of granuloma formation, IL-12 helps in the generation of effective cell-mediated immune response in tuberculosis. NO shows an ability to inhibit mycobacterial infection by inducing innate-cytotoxic response and by increasing IL-8 induction. However, it may become a problem in later phase when it converts a protective Th1 response to a subversive Th2 response mainly by inhibiting IL-12 cytokine, thus acting as a potential regulator of Th1/Th2 response. This review intends to explore the possibilities that can be envisioned for exploring NO from immunotherapeutic perspectives in mycobacterial immunity.
Export Options
About this article
Cite this article as:
Mukhopadhyay Sangita, Nair Shiny and Hasnain E. Seyed, Nitric Oxide: Friendly Rivalry in Tuberculosis, Current Signal Transduction Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157436207780619536
DOI https://dx.doi.org/10.2174/157436207780619536 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Systematic Review of Lifestyle Modification and Glucose Intolerance in the Prevention of Type 2 Diabetes
Current Diabetes Reviews Hybrid Compounds Containing Carvacrol Scaffold: <i>In Vitro</i> Antibacterial and Cytotoxicity Evaluation
Recent Advances in Anti-Infective Drug Discovery Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Current Pharmaceutical Design A Brief Review of the Computational Identification of Antifreeze Protein
Current Organic Chemistry Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones
Mini-Reviews in Medicinal Chemistry A Mathematical Approach for the Simultaneous In Vitro Spectrophotometric Analysis of Rifampicin and Isoniazid from Modified-Release Anti-TB Drug Delivery Systems
Current Drug Delivery Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African Setting
Current HIV Research Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology Research Progress in Live Attenuated Brucella Vaccine Development
Current Pharmaceutical Biotechnology Structure and Functions of Bacterial Outer Membrane Protein A, A Potential Therapeutic Target for Bacterial Infection
Current Topics in Medicinal Chemistry Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design Melatonin in Bacterial and Viral Infections with Focus on Sepsis: A Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery Structural Analysis of Dihydrofolate Reductase and Thymidylate Synthase from Mammalian and Pathogenic Organisms
Current Enzyme Inhibition Small Molecule Hydrazide Agents to Inhibit Growth and Proliferation of Mycobacterium Tuberculosis
Medicinal Chemistry Microwave Assisted Organic Synthesis of Heterocycles in Aqueous Media: Recent Advances in Medicinal Chemistry
Medicinal Chemistry Computational Biology in Anti-Tuberculosis Drug Discovery
Infectious Disorders - Drug Targets Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes
Current Topics in Medicinal Chemistry Are Bacteriocins Underexploited? NOVEL Applications for OLD Antimicrobials
Current Pharmaceutical Biotechnology